Formulary Search Results for: CALCIUM AND VITAMIN D
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
The use for the treatment of HIV-1 infection in treatment naive adults, or treatment experienced adults without known mutations associated with resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class, tenofovir or emtricitabine, and with viral load ≤100,000 HIV-1 RNA copies/mL, is restricted to HIV specialists only.
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
- The treatment of HIV infection is restricted to use by HIV specialists.
- Use in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults at high risk is restricted to specialist use only by consultants in sexual health and infectious disease consultants.
Prescribing Notes:
Preferred preparation for PrEP in NHSGGC.
Non-Formulary indications:
- Treatment of HIV-1 infected adolescents aged 12 to <18 years with nucleoside reverse transcriptase inhibitor resistance or toxicities precluding the use of first-line agents
8.2.5 Immunomodulating drugs used in Multiple Sclerosis - View Category
Restrictions:
Restricted to specialist use for the treatment of relapsing remitting multiple sclerosis in accordance with local guidelines.
8.2.5 Immunomodulating drugs used in Multiple Sclerosis - View Category
Restrictions:
The treatment of adult patients with relapsing remitting multiple sclerosis is restricted to specialist use in accordance with local guidelines.
12.1.2 Otitis media - View Category
Restrictions:
Restricted to use in the treatment of acute otitis media in patients with tympanostomy tubes (AOMT).
9.6.4 Vitamin D - View Category
Prescribing Notes:
Domnisol® is a monthly preparation and could be prescribed for patients where monthly administration would be advantageous. Domnisol® currently is associated with an acquisition cost advantage compared to daily colecalciferol (September 2024).
4.1.1.2 Hypnotics for chronic insomnia - View Category
Restrictions:
Restricted to use in patients where sleep hygiene advice has been unsuccessful and the use of cognitive behavioural therapy for insomnia (CBT-I) has failed or for whom CBT-I is unsuitable or unavailable.
Prescribing Notes:
- For the treatment of adult patients with chronic insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
- Sleepio® is a six-week programme based on CBT-I. Sleepio® is used to treat insomnia and is available free on the NHS. For more information visit Sleep | NHS inform
8.1.2 Anthracyclines and other cytotoxic antibiotics - View Category
5.3.1.4 Other retrovirals - View Category
Restrictions:
The use in combination with other antiretroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults and adolescents above 12 years of age is restricted to use by HIV specialists.